Skip to main content

Table 4 Biomarkers associated with progression of emphysema

From: Multiple biomarkers predict disease severity, progression and mortality in COPD

 

COPDGene

ECLIPSE

Biomarker(s)

β

R2m

AIC

β

R2m

AIC

None

 

0.357

7281

 

0.49

27,783

SP-D

0.045

0.002

7271

0.1722

0.008

27,042

CRP

0.0023

0.002

7264

−0.0004

−0.006

26,891

CC16

−0.419

0.002

7256*

−0.16

0.005

27,056

sRAGE

−0.169

0.005

7103

−0.765

0.04

24,804*

Fibrinogen

−0.218

−0.004

7066

−0.867

0.006

24,968*

CC16, Fibrinogen, sRAGE

 

0.005

7010*a

 

0.043

21,866*

  1. Analysis performed by linear mixed model. Covariates were FEV1, age, time, smoking status, gender, CT scanner, and BMI. The R2 reported for clinical covariates (no biomarkers) is given. The R2 reported for biomarkers refers to the R2 of the biomarkers(s) over clinical covariates alone. *p < 10−3 in a two-sided t-test for the null hypothesis that β = 0
  2. aBest model